Leonard Valentino: Excited to Share The New Perspectives on Hemophilic Arthropathy
Leonard Valentino, Former President and CEO of NBDF, President of WFH USA, recenlty shared a post on LinkedIn about a recent article he and Yesim Dargaud co-authored, published in Haematologica, adding:
”I’m excited to share our latest review in the journal Haematologica: ‘Mechanisms of Blood-Induced Joint Disease in Hemophilia and Potential Novel Targets for Interventions.’
For decades, hemophilic arthropathy has been viewed primarily as a consequence of recurrent joint bleeding. In this review, we explore a broader perspective: hemarthrosis is the initiating event, but iron-driven biological processes are what ultimately fuel chronic joint degeneration.
Our analysis integrates historical observations with emerging insights from molecular biology and single-cell genomics to propose an updated model of blood-induced joint disease.
We highlight how iron deposition following bleeding triggers oxidative stress, inflammation, synovial remodeling, vascular changes, and cartilage injury that can persist long after the bleeding episode itself.
Several emerging mechanisms deserve particular attention:
- Iron-driven oxidative stress as a central driver of synovial and cartilage pathology.
- Endothelial ferroptosis and vascular remodeling as potential contributors to ongoing joint vulnerability and re-bleeding.
- The iRhom2/ADAM17/TNF-α pathway as a key mediator of synovial inflammation and bone loss.
- Activated mast cells and endothelial–fibroblast crosstalk as newly recognized components of the hemophilic joint microenvironment.
- The TNXB–AKT pathway as a potentially important cartilage-protective mechanism that may offer new opportunities for chondroprotection.
The central message of our review is straightforward: preventing bleeding remains essential, but preventing arthropathy may require targeting the biological consequences of blood exposure within the joint.
Looking ahead, therapeutic strategies directed at iron handling, oxidative stress, ferroptosis, inflammatory signaling, fibroblast reprogramming, and cartilage survival pathways may complement modern hemostatic therapies and help preserve lifelong joint health.
I am grateful to my co-author, Dr. Yesim Dargaud, for her collaboration on this work and look forward to the discussions that these concepts may stimulate across the hemophilia community.”
Title: Mechanisms of blood-induced joint disease in hemophilia and potential novel targets for interventions
Authors: Leonard Valentino, Yesim Dargaud
Stay updated on all scientific advances with Hemostasis Today.
-
Jul 25, 2026, 12:11Salma Abosabie: Honored to Have an Oral Presentation on Thromboinflammation at the ISTH 2026
-
Jul 25, 2026, 12:06Christina Hart: New Review on Coagulation Disorders in Philadelphia Chromosome-Negative MPNs
-
Jul 25, 2026, 11:49Meaghan O’Donnell: Highlighting Global Gaps in Haemophilia Carrier Registration at ISTH 2026
-
Jul 25, 2026, 11:43Emmanuel J Favaloro: Honored with the JTH Distinguished Peer Review Award
-
Jul 25, 2026, 11:39Maha Othman: One Thing that Amazed Me at ISTH 2026
-
Jul 25, 2026, 11:34Marwa Mohsen: Proud to Contribute to WHO’s Blood Safety Harmonization Efforts
-
Jul 25, 2026, 11:26Jonathan Furniss: Reflections on Presenting at the ISTH 2026
-
Jul 25, 2026, 11:17Aryan Mathur: Annexin V and Coagulation Factors in Pulmonary Embolism
-
Jul 25, 2026, 11:04Meghan McCarthy: Closing the Diagnostic Gap in Women with Bleeding Disorders